Together, these experiments demonstrate that loss of IRAK1 expression in the tumor cells leads to immunity related tumor clearance where both the activated CD4+ and CD8+ T-cells are directly responsible for suppressing leukemia development. This evidence concerns the gene IRAK1 and neoplasm.